Stephen Man

4.9k total citations
77 papers, 3.7k citations indexed

About

Stephen Man is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Stephen Man has authored 77 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 37 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Stephen Man's work include Immunotherapy and Immune Responses (44 papers), Cervical Cancer and HPV Research (28 papers) and Immune Cell Function and Interaction (19 papers). Stephen Man is often cited by papers focused on Immunotherapy and Immune Responses (44 papers), Cervical Cancer and HPV Research (28 papers) and Immune Cell Function and Interaction (19 papers). Stephen Man collaborates with scholars based in United Kingdom, United States and Netherlands. Stephen Man's co-authors include Alison Fiander, Leszek K. Borysiewicz, A. S. Evans, C. Sharrock, É. Kaminski, Malcolm Adams, Víctor H. Engelhard, Julian Hickling, Simon Stacey and Gavin W. G. Wilkinson and has published in prestigious journals such as The Lancet, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen Man

77 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Man United Kingdom 33 2.3k 1.6k 852 781 376 77 3.7k
Wendy I. White United States 29 1.8k 0.8× 1.3k 0.8× 375 0.4× 623 0.8× 337 0.9× 57 3.7k
Robert W. Tindle Australia 29 1.5k 0.6× 1.2k 0.8× 494 0.6× 738 0.9× 402 1.1× 79 2.8k
Kiyotaka Kuzushima Japan 39 2.2k 0.9× 1.2k 0.7× 2.2k 2.5× 845 1.1× 358 1.0× 123 4.3k
Reiko Namikawa United States 26 1.8k 0.8× 481 0.3× 549 0.6× 661 0.8× 602 1.6× 51 3.5k
Kristin Ladell United Kingdom 33 2.5k 1.1× 605 0.4× 1.0k 1.2× 648 0.8× 309 0.8× 97 3.5k
Marvin S. Reitz United States 36 1.8k 0.8× 1.0k 0.6× 1.5k 1.7× 1.3k 1.7× 476 1.3× 90 5.0k
Michael Rosenzweig United States 36 2.0k 0.8× 1.1k 0.7× 1.2k 1.5× 1.9k 2.4× 515 1.4× 99 5.4k
Louise J. McHeyzer‐Williams United States 26 3.7k 1.6× 447 0.3× 518 0.6× 700 0.9× 234 0.6× 39 4.6k
Gayle C. Bosma United States 21 2.3k 1.0× 495 0.3× 768 0.9× 1.3k 1.7× 562 1.5× 42 4.2k
Kees Weijer Netherlands 40 4.0k 1.7× 539 0.3× 821 1.0× 988 1.3× 796 2.1× 84 5.7k

Countries citing papers authored by Stephen Man

Since Specialization
Citations

This map shows the geographic impact of Stephen Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Man more than expected).

Fields of papers citing papers by Stephen Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Man. The network helps show where Stephen Man may publish in the future.

Co-authorship network of co-authors of Stephen Man

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Man. A scholar is included among the top collaborators of Stephen Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Man. Stephen Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Man, Stephen, James E. Redman, David K. Cole, et al.. (2021). Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells. The Journal of Immunology. 207(4). 1009–1017. 4 indexed citations
2.
Man, Stephen, et al.. (2019). Chronic lymphocytic leukaemia: the role of T cells in a B cell disease. British Journal of Haematology. 186(2). 220–233. 27 indexed citations
3.
Wong, Ryan, Chris Pepper, Paul Brennan, et al.. (2013). Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells. Haematologica. 98(12). 1930–1938. 69 indexed citations
4.
5.
Miners, Kelly L., Garry Dolton, Chris Pepper, et al.. (2011). A Novel Tumor Antigen Derived from Enhanced Degradation of Bax Protein in Human Cancers. Cancer Research. 71(16). 5435–5444. 14 indexed citations
6.
Coles, Steven, Eddie C. Y. Wang, Stephen Man, et al.. (2011). CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia. 25(5). 792–799. 141 indexed citations
7.
Wiesner, Martina, Stephen Man, Bernhard Frankenberger, et al.. (2007). Activated B Cells Mediate Efficient Expansion of Rare Antigen-Specific T Cells. Human Immunology. 68(2). 75–85. 12 indexed citations
8.
Youde, Sarah J., Stephen Man, Glyn Teale, et al.. (2005). Activation of CD40 in Cervical Carcinoma Cells Facilitates CTL Responses and Augments Chemotherapy-Induced Apoptosis. The Journal of Immunology. 174(1). 41–50. 56 indexed citations
9.
Smyth, Lucy J.C., Mariëtte I.E. van Poelgeest, Emma J. Davidson, et al.. (2004). Immunological Responses in Women with Human Papillomavirus Type 16 (HPV-16)-Associated Anogenital Intraepithelial Neoplasia Induced by Heterologous Prime-Boost HPV-16 Oncogene Vaccination. Clinical Cancer Research. 10(9). 2954–2961. 114 indexed citations
10.
Youde, Sarah J., et al.. (2004). Cross‐typic specificity and immunotherapeutic potential of a human HPV16 E7‐specific CTL line. International Journal of Cancer. 114(4). 606–612. 16 indexed citations
11.
Palmowski, Michael J., E Choi, Ian F. Hermans, et al.. (2002). Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols. The Journal of Immunology. 168(9). 4391–4398. 135 indexed citations
12.
Savage, Philip, Aled Clayton, Stephen Man, et al.. (2002). Anti‐viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted hla class I/peptide complexes in scid mice. International Journal of Cancer. 98(4). 561–566. 20 indexed citations
13.
Savage, Philip, Aled Clayton, Stephen Man, et al.. (2002). Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes. British Journal of Cancer. 86(8). 1336–1342. 15 indexed citations
14.
Velders, Markwin P., Sanne Weijzen, Gretchen L. Eiben, et al.. (2001). Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine. The Journal of Immunology. 166(9). 5366–5373. 147 indexed citations
15.
Fiander, Alison, Stephen Man, Leszek K. Borysiewicz, & Gavin W. G. Wilkinson. (1997). Therapeutic Vaccines for Cervical Cancer. BioDrugs. 8(5). 331–338. 3 indexed citations
16.
Gulden, Pamela H., Richard A. Pierce, Jeffrey Shabanowitz, et al.. (1997). A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity. The Journal of Immunology. 158(12). 5797–5804. 40 indexed citations
17.
Man, Stephen, et al.. (1996). High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.. PubMed. 56(23). 5484–9. 63 indexed citations
18.
Sharrock, C., É. Kaminski, & Stephen Man. (1990). Limiting dilution analysis of human T cells: a useful clinical tool. Immunology Today. 11(8). 281–286. 143 indexed citations
19.
Kosmas, Christos, et al.. (1990). The role of humoral and cellular immunity in patients developing human anti-murine immunoglobulin antibody responses after radioimmunotherapy.. PubMed. 10. 85–8. 4 indexed citations
20.
Man, Stephen, Robert I. Lechler, J. R. Batchelor, & C. Sharrock. (1990). Individual variation in the frequency of HLA class II‐specific cytotoxic T lymphocyte precursors. European Journal of Immunology. 20(4). 847–854. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy I. White Breakdown of academic impact, for papers by Robert W. Tindle Breakdown of academic impact, for papers by Kiyotaka Kuzushima Breakdown of academic impact, for papers by Reiko Namikawa Breakdown of academic impact, for papers by Kristin Ladell Breakdown of academic impact, for papers by Marvin S. Reitz Breakdown of academic impact, for papers by Michael Rosenzweig Breakdown of academic impact, for papers by Louise J. McHeyzer‐Williams Breakdown of academic impact, for papers by Gayle C. Bosma Breakdown of academic impact, for papers by Kees Weijer
Rankless by CCL
2026